2025
Posters
- Efficacy and safety of dalbavancin as suppressive therapy
- Peripheral neuropathy during long term therapy with tedizolid
Publications
2024
Publications
2023
Communications orales
- Intra articular injection(s) of active bacteriophages as adjuvant therapy in patients with PJI qualified for open or arthroscopic DAIR followed by suppressive antimicrobial therapy (SAT)
- Exclusive medical treatment combining intraarticular injections of active bacteriophages as adjuvant therapy to antibiotics in patients with S. aureus complex PJI contraindicated for, or refusing, surgery